Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BPMC | HALO | CYTK | ||
| Company | Blueprint Medicines Corp | Halozyme Therapeutic | Cytokinetics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 129.35 | 72.27 | 62.36 | ||
| High | 129.55 | 72.65 | 62.36 | ||
| Low | 129.30 | 71.56 | 61.01 | ||
| Latest | 129.46 | 71.90 | 60.62 | ||
| Change | +0.18 | -0.57 | -1.89 | ||
| % Change | +0.14% | -0.79% | -3.02% | ||
| Volume | 2,980,900 | 92,309 | 152,238 | ||
| 20-Day Average Volume | 4,470,280 | 1,993,456 | 2,143,188 | ||
| Previous Close | 129.28 | 72.47 | 62.51 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 128.60 | 68.61 | 62.76 | ||
| 20-Day Raw Stochastic | 88.49% | 73.52% | 19.83% | ||
| 20-Day Relative Strength | 73.17 | 57.28 | 47.57 | ||
| Weighted Alpha | +17.08 | +32.42 | +16.73 | ||
| Today's Opinion | 100% Buy | 72% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 72% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 24% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 07/10/25 | +0.84% since 01/05/26 | -0.01% since 01/05/26 | ||
| Low | 129.00 on 07/11/25 | 70.94 on 01/06/26 | 61.02 on 01/06/26 | ||
| High | 129.65 on 07/16/25 | 75.59 on 01/07/26 | 66.59 on 01/07/26 | ||
| 1-Month | |||||
| %Chg | +0.96% since 06/17/25 | +15.42% since 12/12/25 | -3.31% since 12/12/25 | ||
| Low | 128.00 on 06/20/25 | 61.69 on 12/15/25 | 58.85 on 01/05/26 | ||
| High | 129.65 on 07/16/25 | 75.59 on 01/07/26 | 70.98 on 12/22/25 | ||
| 3-Month | |||||
| %Chg | +52.86% since 04/17/25 | +12.01% since 10/10/25 | +2.02% since 10/10/25 | ||
| Low | 83.27 on 04/22/25 | 61.22 on 12/11/25 | 54.30 on 10/23/25 | ||
| High | 129.65 on 07/16/25 | 75.59 on 01/07/26 | 70.98 on 12/22/25 | ||
| 6-Month | |||||
| %Chg | +17.64% since 01/17/25 | +25.63% since 07/11/25 | +65.51% since 07/11/25 | ||
| Low | 73.04 on 04/09/25 | 55.64 on 07/21/25 | 32.89 on 08/11/25 | ||
| High | 129.65 on 07/16/25 | 79.50 on 09/23/25 | 70.98 on 12/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,360,786 | 8,522,255 | 7,642,785 | ||
| Shares Outstanding, K | 64,582 | 117,597 | 122,265 | ||
| Annual Sales | 508,820,000 | 1,015,320,000 | 18,470,000 | ||
| Annual Net Income | -67,090,000 | 444,090,000 | -589,530,000 | ||
| Last Quarter Sales | 149,410,000 | 354,260,000 | 1,940,000 | ||
| Last Quarter Net Income | 500,000 | 175,230,000 | -306,180,000 | ||
| 60-Month Beta | 0.89 | 0.94 | 0.55 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.74 on 05/01/25 | 1.72 on 11/03/25 | -1.54 on 11/05/25 | ||
| Latest Earnings Date | 08/07/25 | 02/17/26 | 02/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.62 | 0.00 | ||